These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32017014)

  • 1. Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: A case series study.
    Duhig KE; Webster LM; Sharp A; Gill C; Seed PT; Shennan AH; Myers JE; Chappell LC
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):994-1002. PubMed ID: 32017014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
    Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.
    Espinoza J; Romero R; Nien JK; Gomez R; Kusanovic JP; Gonçalves LF; Medina L; Edwin S; Hassan S; Carstens M; Gonzalez R
    Am J Obstet Gynecol; 2007 Apr; 196(4):326.e1-13. PubMed ID: 17403407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study.
    Chappell LC; Duckworth S; Seed PT; Griffin M; Myers J; Mackillop L; Simpson N; Waugh J; Anumba D; Kenny LC; Redman CW; Shennan AH
    Circulation; 2013 Nov; 128(19):2121-31. PubMed ID: 24190934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
    Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dilba P; Schoedl M; Hund M; Verlohren S
    N Engl J Med; 2016 Jan; 374(1):13-22. PubMed ID: 26735990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study.
    Duckworth S; Griffin M; Seed PT; North R; Myers J; Mackillop L; Simpson N; Waugh J; Anumba D; Kenny LC; Redman CWG; Shennan AH; Chappell LC
    Obstet Gynecol; 2016 Aug; 128(2):245-252. PubMed ID: 27400001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat Placental Growth Factor-Based Testing in Women With Suspected Preterm Preeclampsia: A Stratified Analysis of the PARROT-2 Trial.
    Hurrell A; Webster L; Sparkes J; Battersby C; Brockbank A; Clark K; Duhig KE; Gill C; Green M; Hunter RM; Seed PT; Vowles Z; Myers J; Shennan AH; Chappell LC;
    Hypertension; 2024 Jul; 81(7):1561-1573. PubMed ID: 38708607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study.
    McCarthy FP; Gill C; Seed PT; Bramham K; Chappell LC; Shennan AH
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):62-67. PubMed ID: 29575304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women: A Systematic Review and Meta-Analysis.
    Agrawal S; Shinar S; Cerdeira AS; Redman C; Vatish M
    Hypertension; 2019 Nov; 74(5):1124-1135. PubMed ID: 31522621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
    Barton JR; Woelkers DA; Newman RB; Combs CA; How HY; Boggess KA; Martin JN; Kupfer K; Sibai BM;
    Am J Obstet Gynecol; 2020 Mar; 222(3):259.e1-259.e11. PubMed ID: 31518550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [USING MATERNAL SERUM PLACENTAL GROWTH FACTOR (PLGF) FOR RULING OUT PREECLAMPSIA NEAR DELIVERY: PRELIMINARY RESULTS AND ECONOMIC IMPLICATIONS IN ISRAEL].
    Tsviban A; Maymon R; Meiri H; Wiener Y
    Harefuah; 2020 Jul; 159(7):492-497. PubMed ID: 32720766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
    Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2).
    Hurrell A; Sparkes J; Duhig K; Seed PT; Myers J; Battersby C; Clark K; Green M; Hunter RM; Shennan AH; Chappell LC; Webster L
    Trials; 2022 Sep; 23(1):722. PubMed ID: 36056408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique.
    Manriquez Rocha B; Mbofana F; Loquiha O; Mudenyanga C; Ukah UV; Magee LA; von Dadelszen P
    Pregnancy Hypertens; 2018 Jan; 11():26-31. PubMed ID: 29523269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
    Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
    Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
    Sabrià E; Lequerica-Fernández P; Ganuza PL; Ángeles EE; Escudero AI; Martínez-Morillo E; Alvárez FV
    Clin Chem Lab Med; 2018 Jan; 56(2):303-311. PubMed ID: 28841572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique.
    Ukah UV; Mbofana F; Rocha BM; Loquiha O; Mudenyanga C; Usta M; Urso M; Drebit S; Magee LA; von Dadelszen P
    Hypertension; 2017 Mar; 69(3):469-474. PubMed ID: 28137987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial.
    Duhig KE; Myers JE; Gale C; Girling JC; Harding K; Sharp A; Simpson NAB; Tuffnell D; Seed PT; Shennan AH; Chappell LC
    Pregnancy Hypertens; 2021 Mar; 23():41-47. PubMed ID: 33221705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.